Log in to save to my catalogue

Thromboxane A2 receptor antagonist SQ29548 reduces ischemic stroke-induced microglia/macrophages act...

Thromboxane A2 receptor antagonist SQ29548 reduces ischemic stroke-induced microglia/macrophages act...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5075919

Thromboxane A2 receptor antagonist SQ29548 reduces ischemic stroke-induced microglia/macrophages activation and enrichment, and ameliorates brain injury

About this item

Full title

Thromboxane A2 receptor antagonist SQ29548 reduces ischemic stroke-induced microglia/macrophages activation and enrichment, and ameliorates brain injury

Publisher

London: Nature Publishing Group UK

Journal title

Scientific reports, 2016-10, Vol.6 (1), p.35885-35885, Article 35885

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Thromboxane A2 receptor (TXA2R) activation is thought to be involved in thrombosis/hemostasis and inflammation responses. We have previously shown that TXA2R antagonist SQ29548 attenuates BV2 microglia activation by suppression of ERK pathway, but its effect is not tested
in vivo
. The present study aims to explore the role of TXA2R on microg...

Alternative Titles

Full title

Thromboxane A2 receptor antagonist SQ29548 reduces ischemic stroke-induced microglia/macrophages activation and enrichment, and ameliorates brain injury

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5075919

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5075919

Other Identifiers

ISSN

2045-2322

E-ISSN

2045-2322

DOI

10.1038/srep35885

How to access this item